USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| May 18, 2022 | Mar 2022 | $-0.18 | $-0.21 | $-0.43 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| May 18, 2022 | Mar 2022 | $120.00K | $-84.00K | $157.00K |
Entera Bio Ltd's next earnings date is Wednesday, May 18, 2022 for the fiscal quarter ending Mar 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 4 | $-0.19 | $-0.24 | $-0.14 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $-0.81 | $-0.95 | $-0.61 |
| Dec 2023 | 4 | $-0.84 | $-1.07 | $-0.64 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $-0.13 | $-0.13 | $-0.15 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-0.59 | $-0.59 | $-0.61 |
| Dec 2023 | 0 / 0 | $-0.65 | $-0.65 | $-0.78 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 3 | $110.00K | $0.00 | $200.00K |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $510.00K | $0.00 | $840.00K |
| Dec 2023 | 3 | $680.00K | $0.00 | $1.23M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 18, 2022 | Mar 2022 | $-0.16 | - | - |
| Mar 8, 2022 | Dec 2021 | $-0.23 | $-0.21 | 8.70% |
| Nov 10, 2021 | Sep 2021 | $-0.12 | $-0.05 | 56.52% |
| Aug 16, 2021 | Jun 2021 | $-0.12 | $-0.21 | -75.00% |
| May 20, 2021 | Mar 2021 | $-0.12 | $-0.43 | -258.33% |
| Mar 18, 2021 | Dec 2020 | $-0.14 | $-0.12 | 14.29% |
| Nov 19, 2020 | Sep 2020 | $-0.20 | $-0.09 | 55.00% |
| Aug 20, 2020 | Jun 2020 | $-0.12 | $-0.17 | -41.67% |
| May 21, 2020 | Mar 2020 | - | $-0.16 | - |
| Mar 26, 2020 | Dec 2019 | $-0.19 | $-0.26 | -36.84% |
| Nov 21, 2019 | Sep 2019 | $-0.15 | $-0.25 | -66.67% |
| Aug 20, 2019 | Jun 2019 | $-0.28 | $-0.12 | 57.14% |
| Jun 27, 2019 | Mar 2019 | - | $-0.26 | - |
| Mar 28, 2019 | Dec 2018 | $-0.35 | $-0.17 | 51.43% |
| Sep 30, 2018 | Sep 2018 | $-0.28 | $-0.45 | -60.71% |
| Aug 20, 2018 | Jun 2018 | $-0.08 | $-0.93 | -1062.50% |
| Jun 29, 2018 | Mar 2018 | $-0.08 | $-13.97 | -17362.50% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $-1.05 | $-0.90 | - |
| Mar 18, 2021 | Dec 2020 | $-0.56 | $-0.54 | - |
| Mar 26, 2020 | Dec 2019 | $0.00 | $-0.89 | - |
| Mar 28, 2019 | Dec 2018 | $-1.48 | $-15.52 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 18, 2022 | Mar 2022 | $120.00K | - | - |
| Mar 8, 2022 | Dec 2021 | $130.00K | $-84.00K | - |
| Nov 10, 2021 | Sep 2021 | $60.00K | $140.00K | 2.33% |
| Aug 16, 2021 | Jun 2021 | $109.00K | $109.00K | 1.00% |
| May 20, 2021 | Mar 2021 | $90.00K | $157.00K | 1.74% |
| Mar 18, 2021 | Dec 2020 | $0.00 | $221.00K | - |
| Nov 19, 2020 | Sep 2020 | $0.00 | $50.00K | - |
| Aug 20, 2020 | Jun 2020 | - | $52.00K | - |
| May 21, 2020 | Mar 2020 | $42.00K | $42.00K | 1.00% |
| Mar 26, 2020 | Dec 2019 | $102.00K | $102.00K | 1.00% |
| Nov 21, 2019 | Sep 2019 | $0.00 | $60.00K | - |
| Aug 20, 2019 | Jun 2019 | $0.00 | $74.00K | - |
| Jun 27, 2019 | Mar 2019 | $0.00 | $500.00K | - |
| Mar 28, 2019 | Dec 2018 | $0.00 | $500.00K | - |
| Sep 30, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 20, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| Jun 29, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $480.00K | $571.00K | 18.96% |
| Mar 18, 2021 | Dec 2020 | $140.00K | $365.00K | 160.71% |
| Mar 26, 2020 | Dec 2019 | $236.00K | $236.00K | 0.00% |
| Mar 28, 2019 | Dec 2018 | $0.00 | $500.00K | - |
ENTX's next earnings date is Wednesday, May 18, 2022 for the fiscal quarter ending Mar 31, 2022.
According to 4 analysts, the average EPS estimation for Entera Bio Ltd's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.20, and a high estimation of $-0.16.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.15, the last 2 month trend is $-0.15, and the 3 month trend is $-0.16.
Based on 2 analysts, the average revenue estimation is $120.00K, with a low revenue estimation of $0.00, and a high estimation of $180.00K.
Entera Bio Ltd's previous earnings date was Mar 8, 2022 for its fiscal quarter ended Dec 31, 2021.
ENTX's earnings per share (EPS) was $-0.21, beating the consensus analysts forecast of $-0.23 by 8.70%.
The EPS was lower than the previous fiscal quarter (Sep 2021) by 320.00%, and lower than the same period a year before (Dec 2020) by 75.00%.
Revenues were $-84.00K.
The company reported a net income of $29.29M.Free cash flow for the quarter was $-2.67M , compared to $-2.06M last quarter and $-1.40M a year before.
ENTX ended the quarter with $302.00K in total debt, a decrease of -9.04% compared to the previous quarter, and a decrease of -30.09% compared to the same quarter a year before.
Entera Bio Ltd's previous annual earnings date was Mar 8, 2022 for its fiscal year ended Dec 31, 2021.
ENTX's earnings per share (EPS) was $-0.90, beating the consensus analysts forecast of $-1.05 by -14.29% , and lower than the previous year's EPS (Dec 2020) by 66.14%.
Revenues were $571.00K, better than the forecast of $480.00K by 18.96%, and up by 56.44% from previous year's revenue.
The company reported a net income of $12.19M.
Entera Bio Ltd reported a free cash flow of $-9.08M for its fiscal year, compared to $-10.48M a year ago.
The company ended the fiscal year with $302.00K in total debt, a decrease of -30.09% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
